Genetic basis for variation in plasma IL-18 levels in persons with chronic hepatitis C virus and human immunodeficiency virus-1 infections
- PMID: 28300059
- PMCID: PMC5408324
- DOI: 10.1038/gene.2017.2
Genetic basis for variation in plasma IL-18 levels in persons with chronic hepatitis C virus and human immunodeficiency virus-1 infections
Abstract
Inflammasomes are multi-protein complexes integrating pathogen-triggered signaling leading to the generation of pro-inflammatory cytokines including interleukin-18 (IL-18). Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infections are associated with elevated IL-18, suggesting inflammasome activation. However, there is marked person-to-person variation in the inflammasome response to HCV and HIV. We hypothesized that host genetics may explain this variation. To test this, we analyzed the associations of plasma IL-18 levels and polymorphisms in 10 genes in the inflammasome cascade. About 1538 participants with active HIV and/or HCV infection in three ancestry groups are included. Samples were genotyped using the Illumina Omni 1-quad and Omni 2.5 arrays. Linear regression analyses were performed to test the association of variants with log IL-18 including HCV and HIV infection status, and HIV RNA in each ancestry group and then meta-analyzed. Eleven highly correlated single-nucleotide polymorphisms (r2=0.98-1) in the IL-18-BCO2 region were significantly associated with log IL-18; each T allele of rs80011693 confers a decrease of 0.06 log pg ml-1 of IL-18 after adjusting for covariates (rs80011693; rs111311302 β=-0.06, P-value=2.7 × 10-4). In conclusion, genetic variation in IL-18 is associated with IL-18 production in response to HIV and HCV infection, and may explain variability in the inflammatory outcomes of chronic viral infections.
Conflict of interest statement
Figures


Similar articles
-
HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection.PLoS One. 2016 Apr 28;11(4):e0154433. doi: 10.1371/journal.pone.0154433. eCollection 2016. PLoS One. 2016. PMID: 27124305 Free PMC article.
-
HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon.PLoS Pathog. 2014 May 1;10(5):e1004082. doi: 10.1371/journal.ppat.1004082. eCollection 2014 May. PLoS Pathog. 2014. PMID: 24788318 Free PMC article.
-
Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infection.Clin Vaccine Immunol. 2007 Sep;14(9):1127-37. doi: 10.1128/CVI.00141-07. Epub 2007 Jul 18. Clin Vaccine Immunol. 2007. PMID: 17634507 Free PMC article.
-
Association of plasma interleukin-18 levels and polymorphisms in interleukin-18 gene with outcomes of hepatitis C virus infections: a meta-analysis.J Immunoassay Immunochem. 2015;36(3):221-32. doi: 10.1080/15321819.2014.924418. J Immunoassay Immunochem. 2015. PMID: 24906108 Review.
-
Virologic and immunologic aspects of HIV-hepatitis C virus coinfection.AIDS. 2016 Oct 23;30(16):2395-2404. doi: 10.1097/QAD.0000000000001203. AIDS. 2016. PMID: 27427873 Free PMC article. Review.
Cited by
-
Inflammasomes and their roles in the pathogenesis of viral hepatitis and their related complications: An updated systematic review.Immunol Lett. 2019 Apr;208:11-18. doi: 10.1016/j.imlet.2019.03.001. Epub 2019 Mar 1. Immunol Lett. 2019. PMID: 30831142 Free PMC article.
-
Innate Immune Gene Polymorphisms and COVID-19 Prognosis.Viruses. 2023 Aug 22;15(9):1784. doi: 10.3390/v15091784. Viruses. 2023. PMID: 37766191 Free PMC article.
-
Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation.J Infect Dis. 2020 Sep 14;222(8):1334-1344. doi: 10.1093/infdis/jiaa254. J Infect Dis. 2020. PMID: 32406487 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
- U01 DA036297/DA/NIDA NIH HHS/United States
- R38 AI140299/AI/NIAID NIH HHS/United States
- U01 AI103397/AI/NIAID NIH HHS/United States
- U01 AI031834/AI/NIAID NIH HHS/United States
- R01 DA033541/DA/NIDA NIH HHS/United States
- K23 AI124913/AI/NIAID NIH HHS/United States
- U01 AI034989/AI/NIAID NIH HHS/United States
- U19 AI082630/AI/NIAID NIH HHS/United States
- UL1 TR000454/TR/NCATS NIH HHS/United States
- K24 AI118591/AI/NIAID NIH HHS/United States
- R01 DA012568/DA/NIDA NIH HHS/United States
- UL1 TR000004/TR/NCATS NIH HHS/United States
- U01 AI103408/AI/NIAID NIH HHS/United States
- U54 AG062334/AG/NIA NIH HHS/United States
- KL2 TR000143/TR/NCATS NIH HHS/United States
- U01 AI035004/AI/NIAID NIH HHS/United States
- R01 DA013324/DA/NIDA NIH HHS/United States
- U01 AI034994/AI/NIAID NIH HHS/United States
- U19 AI066345/AI/NIAID NIH HHS/United States
- U01 AI103401/AI/NIAID NIH HHS/United States
- U01 AI131314/AI/NIAID NIH HHS/United States
- U01 AI103390/AI/NIAID NIH HHS/United States
- U01 AI034993/AI/NIAID NIH HHS/United States
- R01 AI108403/AI/NIAID NIH HHS/United States
- U01 HL146203/HL/NHLBI NIH HHS/United States
- P30 AI050410/AI/NIAID NIH HHS/United States
- U01 HD032632/HD/NICHD NIH HHS/United States
- U01 AI042590/AI/NIAID NIH HHS/United States
- U19 AI088791/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous